SLC6A12 | Solute carrier family 6 (neurotransmitter transporter), member 12 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC6A13 | Solute carrier family 6 (neurotransmitter transporter), member 13 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
KDM5A | Lysine (K)-specific demethylase 5A | Cancer-related genes Transcription factors
| | | | | Expressed in all |
CCDC77 | Coiled-coil domain containing 77 | | | | | | Expressed in all |
B4GALNT3 | Beta-1,4-N-acetyl-galactosaminyl transferase 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
NINJ2 | Ninjurin 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
WNK1 | WNK lysine deficient protein kinase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ERC1 | ELKS/RAB6-interacting/CAST family member 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
FBXL14 | F-box and leucine-rich repeat protein 14 | | | | | | Expressed in all |
ADIPOR2 | Adiponectin receptor 2 | Predicted membrane proteins
| | | | | Expressed in all |
CACNA2D4 | Calcium channel, voltage-dependent, alpha 2/delta subunit 4 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
LRTM2 | Leucine-rich repeats and transmembrane domains 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
DCP1B | Decapping mRNA 1B | | | | | | Expressed in all |
CACNA1C | Calcium channel, voltage-dependent, L type, alpha 1C subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
FKBP4 | FK506 binding protein 4, 59kDa | Enzymes Plasma proteins
| | | | | Expressed in all |
ITFG2 | Integrin alpha FG-GAP repeat containing 2 | | | | | | Expressed in all |
NRIP2 | Nuclear receptor interacting protein 2 | | | | | | Mixed |
AC005841.1 | Uncharacterized protein ENSP00000372125 | | | | | | Tissue enhanced |
FOXM1 | Forkhead box M1 | Cancer-related genes Transcription factors
| | | | | Mixed |
RHNO1 | RAD9-HUS1-RAD1 interacting nuclear orphan 1 | | | | | | Expressed in all |
TULP3 | Tubby like protein 3 | | | | | | Expressed in all |
TEAD4 | TEA domain family member 4 | Transcription factors
| | | | | Tissue enhanced |
TSPAN9 | Tetraspanin 9 | Predicted membrane proteins
| | | | | Tissue enhanced |
PRMT8 | Protein arginine methyltransferase 8 | | | | | | Tissue enriched |
EFCAB4B | EF-hand calcium binding domain 4B | | | | | | Tissue enhanced |
PARP11 | Poly (ADP-ribose) polymerase family, member 11 | Enzymes
| | | | | Mixed |
CCND2 | Cyclin D2 | Cancer-related genes
| | | | | Mixed |
C12orf5 | Chromosome 12 open reading frame 5 | Enzymes
| | | | | Mixed |
C12orf4 | Chromosome 12 open reading frame 4 | | | | | | Expressed in all |
RAD51AP1 | RAD51 associated protein 1 | | | | | | Mixed |
DYRK4 | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 | Enzymes
| | | | | Expressed in all |
AKAP3 | A kinase (PRKA) anchor protein 3 | | | | | | Tissue enriched |
NDUFA9 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa | Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
GALNT8 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
KCNA6 | Potassium voltage-gated channel, shaker-related subfamily, member 6 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KCNA1 | Potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KCNA5 | Potassium voltage-gated channel, shaker-related subfamily, member 5 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
NTF3 | Neurotrophin 3 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ANO2 | Anoctamin 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
VWF | Von Willebrand factor | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Mixed |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PLEKHG6 | Pleckstrin homology domain containing, family G (with RhoGef domain) member 6 | | | | | | Tissue enhanced |
TNFRSF1A | Tumor necrosis factor receptor superfamily, member 1A | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
SCNN1A | Sodium channel, non-voltage-gated 1 alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
LTBR | Lymphotoxin beta receptor (TNFR superfamily, member 3) | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
TAPBPL | TAP binding protein-like | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
VAMP1 | Vesicle-associated membrane protein 1 (synaptobrevin 1) | FDA approved drug targets Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
MRPL51 | Mitochondrial ribosomal protein L51 | Mitochondrial proteins
| | | | | Expressed in all |
NCAPD2 | Non-SMC condensin I complex, subunit D2 | Plasma proteins
| | | | | Expressed in all |